Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

44.46 -1.28 (-2.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 831,055
Open 45.54
Bid (Size) 44.25 (1)
Ask (Size) 44.40 (4)
Prev. Close 45.74
Today's Range 44.08 - 46.05
52wk Range 38.94 - 86.95
Shares Outstanding 78,646,679
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow. 
Via InvestorPlace
3 Beaten-Down Stocks That Could Soar This Year
These stocks could enjoy big rebounds in 2023. 
Via The Motley Fool

Performance

YTD
+8.44%
+8.44%
1 Month
-12.64%
-12.64%
3 Month
+0.91%
+0.91%
6 Month
-35.40%
-35.40%
1 Year
-32.29%
-32.29%

More News

Read More
2 Top Biotech Stocks to Buy for the Long Haul
Via The Motley Fool
If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today
Via The Motley Fool
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
Via The Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
Via The Motley Fool
Expert Ratings for CRISPR Therapeutics
Via Benzinga
Looking Into CRISPR Therapeutics's Return On Invested Capital
Via Benzinga
Beat the Dow Jones With CRISPR Therapeutics Stock
Via The Motley Fool
7 Cathie Wood Stocks for Your March Buy List
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
Via InvestorPlace
Better Growth Stock: Moderna vs. CRISPR Therapeutics
Via The Motley Fool
3 Things About CRISPR Therapeutics That Smart Investors Know
Via The Motley Fool
3 Game-Changing Stocks to Buy in March
Via The Motley Fool
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
Via The Motley Fool
10 Best Stocks to Buy in March 2023
Via The Motley Fool
Here's How Much You Can Make From Investing Your Tax Return Every Year
Via The Motley Fool
Better Buy: Beam Therapeutics or Intellia Therapeutics?
Via The Motley Fool
2 Bruised Growth Stocks to Buy While They're Cheap
Via The Motley Fool
SMID Cap Life Science Update: Are You An Investor Or Trader?
Via Talk Markets
2 Marvelous Growth Stocks to Buy Today and Hold for 5 Years or Longer
Via The Motley Fool
These 2 Biotech Stocks Could Soar in the Next Bull Market
Via The Motley Fool
3 Prime Healthcare Takeover Targets
Via The Motley Fool
The Best Stocks To Invest $5,000 in Right Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.